208 related articles for article (PubMed ID: 14977972)
21. Trimer stability of YadA is critical for virulence of Yersinia enterocolitica.
Schütz M; Weiss EM; Schindler M; Hallström T; Zipfel PF; Linke D; Autenrieth IB
Infect Immun; 2010 Jun; 78(6):2677-90. PubMed ID: 20308293
[TBL] [Abstract][Full Text] [Related]
22. Transforming growth factor beta and CD25 are important for controlling systemic dissemination following Yersinia enterocolitica infection of the gut.
Zhong Y; Cantwell A; Dube PH
Infect Immun; 2010 Sep; 78(9):3716-25. PubMed ID: 20584975
[TBL] [Abstract][Full Text] [Related]
23. Pathogenesis of defined invasion mutants of Yersinia enterocolitica in a BALB/c mouse model of infection.
Pepe JC; Wachtel MR; Wagar E; Miller VL
Infect Immun; 1995 Dec; 63(12):4837-48. PubMed ID: 7591144
[TBL] [Abstract][Full Text] [Related]
24. Morphology of intestinal colonization of Yersinia enterocolitica serovar O3 in mice.
Kaneko K; Uehara K; Hayashidani H; Ogawa M
J Vet Med Sci; 1999 Oct; 61(10):1171-3. PubMed ID: 10563299
[TBL] [Abstract][Full Text] [Related]
25. Pattern of macrophage activation in yersinia-resistant and yersinia-susceptible strains of mice.
Tumitan AR; Monnazzi LG; Ghiraldi FR; Cilli EM; Machado de Medeiros BM
Microbiol Immunol; 2007; 51(10):1021-8. PubMed ID: 17951992
[TBL] [Abstract][Full Text] [Related]
26. Contribution of the major secreted yops of Yersinia enterocolitica O:8 to pathogenicity in the mouse infection model.
Trülzsch K; Sporleder T; Igwe EI; Rüssmann H; Heesemann J
Infect Immun; 2004 Sep; 72(9):5227-34. PubMed ID: 15322017
[TBL] [Abstract][Full Text] [Related]
27. Yersinia enterocolitica infection of mice reveals clonal invasion and abscess formation.
Oellerich MF; Jacobi CA; Freund S; Niedung K; Bach A; Heesemann J; Trülzsch K
Infect Immun; 2007 Aug; 75(8):3802-11. PubMed ID: 17562774
[TBL] [Abstract][Full Text] [Related]
28. Resistance of chemokine receptor 6-deficient mice to Yersinia enterocolitica infection: evidence of defective M-cell formation in vivo.
Westphal S; Lügering A; von Wedel J; von Eiff C; Maaser C; Spahn T; Heusipp G; Schmidt MA; Herbst H; Williams IR; Domschke W; Kucharzik T
Am J Pathol; 2008 Mar; 172(3):671-80. PubMed ID: 18258848
[TBL] [Abstract][Full Text] [Related]
29. Lipopolysaccharide O antigen status of Yersinia enterocolitica O:8 is essential for virulence and absence of O antigen affects the expression of other Yersinia virulence factors.
Bengoechea JA; Najdenski H; Skurnik M
Mol Microbiol; 2004 Apr; 52(2):451-69. PubMed ID: 15066033
[TBL] [Abstract][Full Text] [Related]
30. Pathogenicity of various Yersinia enterocolitica serotypes towards mice of Swiss and Balb/c strains.
Zaremba M
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):611-7. PubMed ID: 749814
[TBL] [Abstract][Full Text] [Related]
31. The cellular immune response against Yersinia enterocolitica in different inbred strains of mice: evidence for an important role of T lymphocytes.
Autenrieth IB; Beer M; Hantschmann P; Preger S; Vogel U; Heymer B; Heesemann J
Zentralbl Bakteriol; 1993 Apr; 278(2-3):383-95. PubMed ID: 8347942
[TBL] [Abstract][Full Text] [Related]
32. A Lactobacillus plantarum strain isolated from kefir protects against intestinal infection with Yersinia enterocolitica O9 and modulates immunity in mice.
De Montijo-Prieto S; Moreno E; Bergillos-Meca T; Lasserrot A; Ruiz-López MD; Ruiz-Bravo A; Jiménez-Valera M
Res Microbiol; 2015 Oct; 166(8):626-32. PubMed ID: 26272025
[TBL] [Abstract][Full Text] [Related]
33. IgA response by oral infection with an attenuated Yersinia enterocolitica mutant: implications for its use as oral carrier vaccine.
Blanco HM; Lacoste MG; Eliçabe RJ; Di Genaro MS
Vaccine; 2008 Dec; 26(51):6497-502. PubMed ID: 18835575
[TBL] [Abstract][Full Text] [Related]
34. In vivo analysis of Yersinia enterocolitica infection using luxCDABE.
Trcek J; Berschl K; Trülzsch K
FEMS Microbiol Lett; 2010 Jun; 307(2):201-6. PubMed ID: 20636977
[TBL] [Abstract][Full Text] [Related]
35. Characterization of a novel porin involved in systemic Yersinia enterocolitica infection.
Mildiner-Earley S; Miller VL
Infect Immun; 2006 Jul; 74(7):4361-5. PubMed ID: 16790812
[TBL] [Abstract][Full Text] [Related]
36. Immune responses to Yersinia enterocolitica in susceptible BALB/c and resistant C57BL/6 mice: an essential role for gamma interferon.
Autenrieth IB; Beer M; Bohn E; Kaufmann SH; Heesemann J
Infect Immun; 1994 Jun; 62(6):2590-9. PubMed ID: 8188382
[TBL] [Abstract][Full Text] [Related]
37. Comparison of Growth and the Cytokines Induced by Pathogenic
Yang H; Gu W; Qiu H; Sun G; Liang J; Li K; Xiao Y; Duan R; Jing H; Wang X
Front Cell Infect Microbiol; 2017; 7():158. PubMed ID: 28507952
[TBL] [Abstract][Full Text] [Related]
38. Experimental Yersinia enterocolitica infection in rodents: a model for human yersiniosis.
Heesemann J; Gaede K; Autenrieth IB
APMIS; 1993 Jun; 101(6):417-29. PubMed ID: 8363822
[TBL] [Abstract][Full Text] [Related]
39. The rovA mutant of Yersinia enterocolitica displays differential degrees of virulence depending on the route of infection.
Dube PH; Handley SA; Revell PA; Miller VL
Infect Immun; 2003 Jun; 71(6):3512-20. PubMed ID: 12761136
[TBL] [Abstract][Full Text] [Related]
40. Desferrioxamine-promoted virulence of Yersinia enterocolitica in mice depends on both desferrioxamine type and mouse strain.
Autenrieth IB; Reissbrodt R; Saken E; Berner R; Vogel U; Rabsch W; Heesemann J
J Infect Dis; 1994 Mar; 169(3):562-7. PubMed ID: 8158027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
